Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion.

Parker HE, Adriaenssens A, Rogers G, Richards P, Koepsell H, Reimann F, Gribble FM.

Diabetologia. 2012 Sep;55(9):2445-55. doi: 10.1007/s00125-012-2585-2. Epub 2012 May 26.

2.

The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine.

Mace OJ, Schindler M, Patel S.

J Physiol. 2012 Jun 15;590(12):2917-36. doi: 10.1113/jphysiol.2011.223800. Epub 2012 Apr 10.

3.

Role of fatty acid transport protein 4 in oleic acid-induced glucagon-like peptide-1 secretion from murine intestinal L cells.

Poreba MA, Dong CX, Li SK, Stahl A, Miner JH, Brubaker PL.

Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E899-907. doi: 10.1152/ajpendo.00116.2012. Epub 2012 Aug 7.

4.

A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line.

Gribble FM, Williams L, Simpson AK, Reimann F.

Diabetes. 2003 May;52(5):1147-54.

5.

Spatiotemporal Modeling of Triggering and Amplifying Pathways in GLP-1 Secreting Intestinal L Cells.

Tagliavini A, Pedersen MG.

Biophys J. 2017 Jan 10;112(1):162-171. doi: 10.1016/j.bpj.2016.11.3199.

6.

Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor.

Diakogiannaki E, Pais R, Tolhurst G, Parker HE, Horscroft J, Rauscher B, Zietek T, Daniel H, Gribble FM, Reimann F.

Diabetologia. 2013 Dec;56(12):2688-96. doi: 10.1007/s00125-013-3037-3. Epub 2013 Sep 18.

7.

Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine.

Kuhre RE, Frost CR, Svendsen B, Holst JJ.

Diabetes. 2015 Feb;64(2):370-82. doi: 10.2337/db14-0807. Epub 2014 Aug 25.

8.

Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells.

Harada K, Kitaguchi T, Kamiya T, Aung KH, Nakamura K, Ohta K, Tsuboi T.

J Biol Chem. 2017 Jun 30;292(26):10855-10864. doi: 10.1074/jbc.M117.788653. Epub 2017 May 22.

PMID:
28533434
9.

Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.

Seino Y, Maekawa R, Ogata H, Hayashi Y.

J Diabetes Investig. 2016 Apr;7 Suppl 1:27-32. doi: 10.1111/jdi.12449. Epub 2016 Mar 14. Review.

10.

Synaptotagmin-7 as a positive regulator of glucose-induced glucagon-like peptide-1 secretion in mice.

Gustavsson N, Wang Y, Kang Y, Seah T, Chua S, Radda GK, Han W.

Diabetologia. 2011 Jul;54(7):1824-30. doi: 10.1007/s00125-011-2119-3. Epub 2011 Mar 22.

PMID:
21424898
11.

Mathematical Modeling of Interacting Glucose-Sensing Mechanisms and Electrical Activity Underlying Glucagon-Like Peptide 1 Secretion.

Riz M, Pedersen MG.

PLoS Comput Biol. 2015 Dec 2;11(12):e1004600. doi: 10.1371/journal.pcbi.1004600. eCollection 2015 Dec.

12.

Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line.

Brubaker PL, Schloos J, Drucker DJ.

Endocrinology. 1998 Oct;139(10):4108-14.

PMID:
9751489
13.

Glucose sensing in L cells: a primary cell study.

Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM.

Cell Metab. 2008 Dec;8(6):532-9. doi: 10.1016/j.cmet.2008.11.002.

14.

Galanin inhibits GLP-1 and GIP secretion via the GAL1 receptor in enteroendocrine L and K cells.

Psichas A, Glass LL, Sharp SJ, Reimann F, Gribble FM.

Br J Pharmacol. 2016 Mar;173(5):888-98. doi: 10.1111/bph.13407. Epub 2016 Feb 8.

15.

Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.

Lan H, Lin HV, Wang CF, Wright MJ, Xu S, Kang L, Juhl K, Hedrick JA, Kowalski TJ.

Br J Pharmacol. 2012 Apr;165(8):2799-807. doi: 10.1111/j.1476-5381.2011.01754.x.

16.

Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells.

Moss CE, Glass LL, Diakogiannaki E, Pais R, Lenaghan C, Smith DM, Wedin M, Bohlooly-Y M, Gribble FM, Reimann F.

Peptides. 2016 Mar;77:16-20. doi: 10.1016/j.peptides.2015.06.012. Epub 2015 Jul 2.

17.

Chronic Exposure to TNFα Impairs Secretion of Glucagon-Like Peptide-1.

Gagnon J, Sauvé M, Zhao W, Stacey HM, Wiber SC, Bolz SS, Brubaker PL.

Endocrinology. 2015 Nov;156(11):3950-60. doi: 10.1210/en.2015-1361. Epub 2015 Aug 13.

PMID:
26270730
18.

RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice.

Pais R, Zietek T, Hauner H, Daniel H, Skurk T.

Am J Physiol Gastrointest Liver Physiol. 2014 Aug 1;307(3):G330-7. doi: 10.1152/ajpgi.00329.2013. Epub 2014 May 29.

PMID:
24875103
19.

Glucose stimulates neurotensin secretion from the rat small intestine by mechanisms involving SGLT1 and GLUT2, leading to cell depolarization and calcium influx.

Kuhre RE, Bechmann LE, Wewer Albrechtsen NJ, Hartmann B, Holst JJ.

Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1123-30. doi: 10.1152/ajpendo.00012.2015. Epub 2015 Apr 21.

PMID:
25898949
20.

Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents.

Moss CE, Marsh WJ, Parker HE, Ogunnowo-Bada E, Riches CH, Habib AM, Evans ML, Gribble FM, Reimann F.

Diabetologia. 2012 Nov;55(11):3094-103. doi: 10.1007/s00125-012-2663-5. Epub 2012 Aug 8.

Supplemental Content

Support Center